Investor Relations
Covalon Annual & Special Meeting of Shareholders
Please note the following change:
| Date: |
|
Wednesday, May 19th, 2010 |
| Time: |
|
2:00 pm (Toronto time) |
| Place: |
|
Stikeman Elliott LLP |
| |
|
53rd floor, Commerce Court West |
| |
|
199 Bay Street |
| |
|
Toronto, Ontario |
The Record Date for the meeting will be April 19, 2010.

Covalon was recognized as a TSX Venture 50™ company in both 2008 and 2007

The TSX Venture 50 are the top 10 companies in each of five major industry sectors - mining, oil & gas, technology & life sciences, diversified industries and cleantech - based on a ranking formula with equal weighting given to one year revenue (last reported 12 months), return on investment, market cap growth and trading volume. All data was as of December 31, 2007, and December 31, 2006, respectively.
TSX Venture 50 is a trade-mark of TSX Inc. and is used under license.
Medical Devices' Silver Bullet
Antimicrobial devices for preventing infections are becoming indispensable components of implantable medical devices. Read the whole story at www.devicelink.com/mpmn/archive/09/07/012.html
Investor Presentation, March 6, 2009
Press Releases
Financial Results 2009-2010
Financial Results 2008-2009
Financial Results 2007-2008
Financial Results 2006-2007

Trading under the symbol COV

Publicly filed documents can also be found via the System for Electronic Document Analysis and Retrieval.
Some documents on this website are in PDF format and require Adobe Acrobat Reader.
Should you need to install this software, click on the Adobe icon.
Additional Information
To receive personalized and specific information, please do not hesitate to contact us.
Covalon Technologies Ltd.
405 Britannia Road East, Suite 106
Mississauga, Ontario L4Z 3E6
tel 905.568.8400
fax 905.568.5200
office@covalon.com
|